SIGA Technologies Announces FDA Accepts NDA and Grants Priority Review for Oral TPOXX to Treat Smallpox Biotech Investing
Myriad’s myRisk® Hereditary Cancer Test Finds More Than 12 Percent of Men with Prostate Cancer Carry an Inherited Genetic Mutation Biotech Investing
Bavarian Nordic Announces Positive Results of Pivotal Phase 3 Study of IMVAMUNE® Smallpox Vaccine Biotech Investing
Cellectar Receives USPTO Notice of Allowance for Patent Covering Use of CLR 131 in Multiple Myeloma Biotech Investing
Keryx Biopharmaceuticals Announces Fourth Quarter and Full Year 2017 Financial Results Biotech Investing
Akari Therapeutics Announces Completion of Phase II COBALT Trial of Coversin in Patients with PNH Biotech Investing
BioDelivery Sciences Announces BELBUCA® Patent Litigation Settlement Agreement with Teva Biotech Investing
Phivida Appoints Former Senior Executive Officer of Red Bull, Samsung, Microsoft as New Chief Marketing Officer Biotech Investing
